Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter? Reumatismo [Internet]. 2016 Dec. 16 [cited 2026 Sep. 4];68(3):144-7. Available from: https://www.reumatismo.org/reuma/article/view/897